Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity

Life Sciences

Volumn 74, Issue 26, 2004, Pages 3211-3222

  Martins, Andréia C P ^a   Souza, Kléber L A ^a,b   Shio, Marina T ^a   Mathias, Paulo C F ^a   Lelkes, Peter I ^c   Garcia, Raúl M G ^d  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b CESUMAR   (Brazil)

^c DREXEL UNIVERSITY   (United States)

^d FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Adrenal Medulla; Obesity; Sympathetic Nervous System; Tyrosine 3 Monooxygenase

Indexed keywords

CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; GLUTAMATE SODIUM; PHENYLETHANOLAMINE N METHYLTRANSFERASE; POTASSIUM; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ADRENAL FUNCTION; ADRENAL GLAND; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BRAIN LEVEL; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; MOUSE; NEWBORN; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION;

ADRENAL MEDULLA; ANIMALS; CATECHOLAMINES; DISEASE MODELS, ANIMAL; DOPAMINE BETA-HYDROXYLASE; FEMALE; HYPOTHALAMIC DISEASES; MICE; MIXED FUNCTION OXYGENASES; OBESITY; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; SODIUM GLUTAMATE; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 13144286078     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.034     Document Type: Article

References (66)

1. Abad F., Garrido B., López M.G., García A.G. The source of calcium for muscarinic-mediated catecholamine release from cat adrenals. Journal of Physiology. 445:1992;725-740.
2. Akaike A., Mine Y., Sasa M., Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. Journal of Pharmacology and Experimental Therapeutics. 255:1990;333-339.
3. Anderson D.J., Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell. 47:1986;1079-1090.
4. Arbogast L.A., Voogt J.L. Sex-related alterations in hypothalamic tyrosine hydroxylase after neonatal monosodium glutamate treatment. Neuroendocrinology. 52:1990;460-467.
5. Astrup A.V., Christensen N.J., Simonsen L., Bulow J. Effects of nutrient intake on sympathoadrenal activity and thermogenic mechanisms. Journal of Neuroscience Methods. 34:1990;187-192.
6. Baile C.A., Herrera M.G., Mayer J. Ventromedial hypothalamus and hyperphagia in hyperglycemic obese mice. American Journal of Physiology. 218:1970;857-863.
7. Bernardis L.L., Patterson B.D. Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. Journal of Endocrinology. 40:1968;527-528.
8. Bray G.A. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. Journal of Nutrition. 121:1991;1146-1162.
9. Bray G.A., Inoue S., Nishizawa Y. Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus. Diabetologia. 20:1981;366-377. (Suppl.).
10. Bunyan J., Murrell E.A., Shah P.P. The induction of obesity in rodents by means of monosodium glutamate. British Journal of Nutrition. 35:1976;25-39.
11. Burgoyne R.D. Control of exocytosis in adrenal chromaffin cell. Biophysica Acta. 1071:1991;174-202.
12. Carlson S.H., Shelton J., White C.R., Wyss J.M. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 35:2000;403-408.
13. Corry D.B., Tuck M.L. Obesity, hypertension, and sympathetic nervous system activity. Current Hypertension Reports. 1:1999;119-126.
14. Cryer P.E., Davis S.N., Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 26:2003;1902-1912.
15. Dahmer M.K., Perlman R.L. Bovine chromaffin cells have insulin-like growth factor-I (IGF-I) receptors: IGF-I enhances catecholamine secretion. Journal of Neurochemistry. 51:1988;321-323.
16. de Araujo e Souza K.L., Garcia R.M., de Freitas Mathias P.C. Glucose does not affect catecholamine stimulus-secretion coupling in rat adrenal medulla: relationship to low changes in osmolarity and to insulin. Research Communications in Molecular Pathology and Pharmacology. 105:1999;200-212.
17. Del Rio G. Adrenomedullary function and its regulation in obesity. International Journal of Obesity and Related Metabolic Disorders. 24(Suppl. 2):2000;S89-S91.
18. Dolnikoff M., Martín-Hidalgo A., Machado U.F., Lima F.B., Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. International Journal of Obesity and Related Metabolic Disorders. 25:2001;426-433.
19. Ebbeling C.B., Pawlak D.B., Ludwig D.S. Childhood obesity: public-health crisis, common sense cure. Lancet. 360:2002;473-482.
20. Fabres-Machado U., Saito M. The effect of adipose cell size on the measurement of GLUT 4 in white adipose tissue of obese mice. Brazilian Journal of Medical and Biological Research. 28:1995;369-376.
21. Finnegan J.M., Borges R., Wightman R.M. Comparison of cytosolic Ca2+ and exocytosis responses from single rat and bovine chromaffin cells. Neuroscience. 71:1996;833-843.
22. Flatt J.P. McCollum Award Lecture, 1995: diet, lifestyle, and weight maintenance. American Journal of Clinical Nutrition. 62:1995;820-836.
23. Graham M.E., Burgoyne R.D. Comparison of cysteine string protein (Csp) and mutant alpha-SNAP overexpression reveals a role for csp in late steps of membrane fusion in dense-core granule exocytosis in adrenal chromaffin cells. Journal of Neuroscience. 20:2000;1281-1289.
24. Grassi G., Seravalle G., Colombo M., Bolla G., Cattaneo B.M., Cavagnini F., Mancia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation. 97:1998;2037-2042.
25. Han P.W., Frohman L.A. Hyperinsulinemia in tube-fed hypophysectomized rats bearing hypothalamic lesions. American Journal of Physiology. 219:1970;1632-1636.
26. Inoue S., Bray G.A. An autonomic hypothesis for hypothalamic obesity. Life Sciences. 25:1979;561-566.
27. Jänig W., McLachlan E.M. Characteristics of function-specific pathways in the sympathetic nervous system. Trends in Neurosciences. 15:1992;475-481.
28. Kaufhold A., Nigam P.K., Dhir R.N., Shapiro B.H. Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate. Journal of Pharmacology and Experimental Therapeutics. 302:2002;490-496.
29. Kelner K.L., Levine R.A., Morita K., Pollard H.B. A comparison of trihydroxyndole and HPLC/electrochemical methods for catecholamine measurement in adrenal chromaffin cells. Neurochemistry International. 7:1985;373-378.
30. Kumer S.C., Vrana K.E. Intricate regulation of tyrosine hydroxylase activity and gene expression. Journal of Neurochemistry. 67:1996;443-462.
31. Lawrence C.B., Turnbull A.V., Rothwell N.J. Hypothalamic control of feeding. Current Opinion in Neurobiology. 9:1999;778-783.
32. Leigh F.S., Kaufman L.N., Young J.B. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. International Journal of Obesity and Related Metabolic Disorders. 16:1992;597-604.
33. Levin B.E., Triscari J., Sullivan A.C. Defective catecholamine metabolism in peripheral organs of genetically obese Zucker rats. Brain Research. 224:1981;353-366.
34. Macdonald I.A. Advances in our understanding of the role of the sympathetic nervous system in obesity. International Journal of Obesity and Related Metabolic Disorders. 19(Suppl. 7):1995;S2-S7.
35. Maiter D., Underwood L.E., Martin J.B., Koenig J.I. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology. 128:1991;1100-1106.
36. Malhotra R.K., Wakade T.D., Wakade A.R. Comparison of secretion of catecholamines from the rat adrenal medulla during continuous exposure to nicotine, muscarine or excess K. Neuroscience. 26:1998;313-320.
37. Martins A.C., Borges H.E., Garcia R.M., Carniatto S.R., Mathias P.C. Monosodium L-glutamate-induced obesity impaired the adrenal medullae activity. Neuroscience Research Communications. 28:2001;49-58.
38. McBride W.J., Hingtgen J.N., Aprison M.H. Neurochemical correlates of behavior: levels of amino acids in four areas of the brain of the rat during drug-induced behavioral excitation. Pharmacology Biochemistry and Behavior. 4:1976;53-57.
39. Menozzi R., Florio P., Bondi M., Luisi S., Cobellis L., Genazzani A.R., Del Rio G., Petraglia F. Neuroendocrinology. 75:2002;124-129.
40. Morita K., Kitayama S., Dohi T. Stimulation of cyclic ADP-ribose synthesis by acetylcholine and its role in catecholamine release in bovine adrenal chromaffin cells. Journal of Biological Chemistry. 272:1997;21002-21009.
41. Nemeroff C.B., Lipton M.A., Kizer J.S. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Developmental Neuroscience. 1:1978;102-109.
42. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 43:2000;533-549.
43. Nonogaki K., Strack A.M., Dallman M.F., Tecott L.H. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nature Medicine. 4:1998;1152-1156.
44. Osipenko O.N., Barrie A.P., Allen J.M., Gurney A.M. Pituitary adenylyl cyclase-activating peptide activates multiple intracellular signaling pathways to regulate ion channels in PC12 cells. Journal of Biological Chemistry. 275:2000;16626-16631.
45. Plut C., Ribiere C., Giudicelli Y., Dausse J.P. Gender differences in hypothalamic tyrosine hydroxylase and alpha(2)-adrenoceptor subtype gene expression in cafeteria diet-induced hypertension and consequences of neonatal androgenization. Journal of Pharmacology and Experimental Therapeutics. 302:2002;525-531.
46. Popkin B.M., Doak C.M. The obesity epidemic is a worldwide phenomenon. Nutrition Reviews. 56:1998;106-114.
47. Quetglas S., Iborra C., Sasakawa N., De Haro L., Kumakura K., Sato K., Leveque C., Seagar M. Calmodulin and lipid binding to synaptobrevin regulates calcium-dependent exocytosis. EMBO Journal. 21:2002;3970-3979.
48. Ravussin E., Tataranni P.A. The role of altered sympathetic nervous system activity in the pathogenesis of obesity. Proceedings of the Nutrition Society. 55:1996;793-802.
49. Rossner S. Obesity: the disease of the twenty-first century. International Journal of Obesity and Related Metabolic Disorders. 26(Suppl. 4):2002;S2-S4.
50. Rumantir M.S., Vaz M., Jennings G.L., Collier G., Kaye D.M., Seals D.R., Wiesner G.H., Brunner-La Rocca H.P., Esler M.D. Neural mechanisms in human obesity-related hypertension. Journal of Hypertension. 17:1999;1125-1133.
51. Scallet A.C., Olney J.W. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Research. 374:1986;380-384.
52. Scheurink A., Ritter S. Sympathoadrenal responses to glucoprivation and lipoprivation in rats. Physiology and Behavior. 53:1993;995-1000.
53. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
54. Souto M., Mariani M.L. Immunochemical localization of chromaffin cells during the embryogenic migration. Biocell. 20:1996;179-184.
55. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes. 40:1991;280-289.
56. Troisi R.J., Weiss S.T., Parker D.R., Sparrow D., Young J.B., Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension. 17:1991;669-677.
57. Tucker J., Trethewey J., Stewart G.A., Neville R.W., Hanley T. Insulin sensitivity and carbohydrate metabolism of rats with hypothalamic obesity. Journal of Endocrinology. 33:1965;437-446.
58. Valensi P., Doare L., Perret G., Germack R., Paries J., Mesangeau D. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity. Obesity Research. 11:2003;54-64.
59. van Dijk G., Scheurink A., Ritter S., Steffens A. Glucose homeostasis and sympathoadrenal activity in mercaptoacetate-treated rats. Physiology and Behavior. 57:1995;759-764.
60. Vander Tuig J.G., Knehans A.W., Romsos D.R. Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions. Life Sciences. 30:1982;913-920.
61. Wilson S.P., Kirshner N. Effects of ascorbic acid, dexamethasone, and insulin on the catecholamine and opioid peptide stores of cultured adrenal medullary chromaffin cells. Journal of Neuroscience. 3:1983;1971-1978.
62. Woods S.C., Porte D. Jr., Bobbioni E., Ionescu E., Sauter J.F., Rohner-Jeanrenaud F., Jeanrenaud B. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. American Journal of Clinical Nutrition. 42:1985;1063-1071.
63. Yamakawa T., Tanaka S., Tamura K., Isoda F., Ukawa K., Yamakura Y., Takanashi Y., Kiuchi Y., Umemura S., Ishii M., Sekihara H. Wistar fatty rat is obese and spontaneously hypertensive. Hypertension. 25:1995;146-150.
64. Yamamoto R., Yanagita T., Kobayashi H., Yuhi T., Yokoo H., Wada A. Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells. Journal of Neurochemistry. 67:1996;1401-1408.
65. Young J.B. Programming of sympathoadrenal function. Trends in Endocrinology and Metabolism. 13:2002;381-385.
66. Young J.B., Macdonald I.A. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. International Journal of Obesity and Related Metabolic Disorders. 16:1992;959-967.